208 related articles for article (PubMed ID: 34885960)
41. Binding of Cu(II) complexes of oxicam NSAIDs to alternating AT and homopolymeric AT sequences: differential response to variation in backbone structure.
Chakraborty S; Sehanobish E; Sarkar M
J Biol Inorg Chem; 2012 Mar; 17(3):475-87. PubMed ID: 22270943
[TBL] [Abstract][Full Text] [Related]
42. Simvastatin modulates chemokine and chemokine receptor expression by geranylgeranyl isoprenoid pathway in human endothelial cells and macrophages.
Veillard NR; Braunersreuther V; Arnaud C; Burger F; Pelli G; Steffens S; Mach F
Atherosclerosis; 2006 Sep; 188(1):51-8. PubMed ID: 16321392
[TBL] [Abstract][Full Text] [Related]
43. Anti-tumor effect of non-steroidal anti-inflammatory drugs on human ovarian cancers.
Xin B; Yokoyama Y; Shigeto T; Mizunuma H
Pathol Oncol Res; 2007; 13(4):365-9. PubMed ID: 18158574
[TBL] [Abstract][Full Text] [Related]
44. Neuropeptide substance P upregulates chemokine and chemokine receptor expression in primary mouse neutrophils.
Sun J; Ramnath RD; Bhatia M
Am J Physiol Cell Physiol; 2007 Aug; 293(2):C696-704. PubMed ID: 17494633
[TBL] [Abstract][Full Text] [Related]
45. Piroxicam-induced fixed drug eruption: Cross-reactivity with meloxicam.
Ben Romdhane H; Ammar H; Ben Fadhel N; Chadli Z; Ben Fredj N; Boughattas NA; Chaabane A; Aouam K
Contact Dermatitis; 2019 Jul; 81(1):24-26. PubMed ID: 30663057
[TBL] [Abstract][Full Text] [Related]
46. Effect of vitamin D3 on chemokine expression in pulmonary tuberculosis.
Selvaraj P; Harishankar M; Singh B; Banurekha VV; Jawahar MS
Cytokine; 2012 Oct; 60(1):212-9. PubMed ID: 22800603
[TBL] [Abstract][Full Text] [Related]
47. Naringin inhibits chemokine production in an LPS-induced RAW 264.7 macrophage cell line.
Liu Y; Su WW; Wang S; Li PB
Mol Med Rep; 2012 Dec; 6(6):1343-50. PubMed ID: 22965302
[TBL] [Abstract][Full Text] [Related]
48. Glomerular expression of C-C chemokines in different types of human crescentic glomerulonephritis.
Liu ZH; Chen SF; Zhou H; Chen HP; Li LS
Nephrol Dial Transplant; 2003 Aug; 18(8):1526-34. PubMed ID: 12897090
[TBL] [Abstract][Full Text] [Related]
49. Immunomodulatory effect of NSAID in geriatric patients with acute infection: effects of piroxicam on chemokine/cytokine secretion patterns and levels of heat shock proteins. A double-blind randomized controlled trial. (ISRCTN58517443).
Beyer I; Njemini R; Bautmans I; Demanet C; Mets T
Cell Stress Chaperones; 2012 Mar; 17(2):255-65. PubMed ID: 22057579
[TBL] [Abstract][Full Text] [Related]
50. Role of chemokines and formyl peptides in pneumococcal pneumonia-induced monocyte/macrophage recruitment.
Fillion I; Ouellet N; Simard M; Bergeron Y; Sato S; Bergeron MG
J Immunol; 2001 Jun; 166(12):7353-61. PubMed ID: 11390486
[TBL] [Abstract][Full Text] [Related]
51. The temporal expression, cellular localization, and inhibition of the chemokines MIP-2 and MCP-1 after traumatic brain injury in the rat.
Rhodes JK; Sharkey J; Andrews PJ
J Neurotrauma; 2009 Apr; 26(4):507-25. PubMed ID: 19210118
[TBL] [Abstract][Full Text] [Related]
52. Comparative biochemical pharmacology of the oxicams.
Fenner H
Eur J Rheumatol Inflamm; 1987; 9(2):3-7. PubMed ID: 3447908
[TBL] [Abstract][Full Text] [Related]
53. TNFalpha-induced macrophage chemokine secretion is more dependent on NF-kappaB expression than lipopolysaccharides-induced macrophage chemokine secretion.
Ciesielski CJ; Andreakos E; Foxwell BM; Feldmann M
Eur J Immunol; 2002 Jul; 32(7):2037-45. PubMed ID: 12115625
[TBL] [Abstract][Full Text] [Related]
54. Release studies from smart hydrogels as carriers for piroxicam and copper(II)-oxicam complexes as anti-inflammatory and anti-cancer drugs. X-ray structures of new copper(II)-piroxicam and -isoxicam complex molecules.
Tamasi G; Serinelli F; Consumi M; Magnani A; Casolaro M; Cini R
J Inorg Biochem; 2008 Oct; 102(10):1862-73. PubMed ID: 18667239
[TBL] [Abstract][Full Text] [Related]
55. Effects of lornoxicam, piroxicam, and meloxicam in a model of thermal hindpaw hyperalgesia induced by formalin injection in rat tail.
Bianchi M; Panerai AE
Pharmacol Res; 2002 Feb; 45(2):101-5. PubMed ID: 11846620
[TBL] [Abstract][Full Text] [Related]
56. Effects of food intake and oxidative stress on intestinal lesions caused by meloxicam and piroxicam in rats.
Villegas I; Alarcón de la Lastra C; La Casa C; Motilva V; Martín MJ
Eur J Pharmacol; 2001 Feb; 414(1):79-86. PubMed ID: 11230998
[TBL] [Abstract][Full Text] [Related]
57. Ankylosing spondylitis: what is the optimum duration of a clinical study? A one year versus a 6 weeks non-steroidal anti-inflammatory drug trial.
Dougados M; Gueguen A; Nakache JP; Velicitat P; Veys EM; Zeidler H; Calin A
Rheumatology (Oxford); 1999 Mar; 38(3):235-44. PubMed ID: 10325662
[TBL] [Abstract][Full Text] [Related]
58. Expression of CC chemokines and their receptors in the eye in autoimmune anterior uveitis associated with EAE.
Adamus G; Manczak M; Machnicki M
Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):2894-903. PubMed ID: 11687534
[TBL] [Abstract][Full Text] [Related]
59. Piroxicam, a traditional non-steroidal anti-inflammatory drug (NSAID) causes apoptosis by ROS mediated Akt activation.
Rai N; Sarkar M; Raha S
Pharmacol Rep; 2015 Dec; 67(6):1215-23. PubMed ID: 26481545
[TBL] [Abstract][Full Text] [Related]
60. Chemokines in human colorectal carcinoma.
Baier PK; Eggstein S; Wolff-Vorbeck G; Baumgartner U; Hopt UT
Anticancer Res; 2005; 25(5):3581-4. PubMed ID: 16101183
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
